[3] At the time the HIV/AIDS epidemic was unfolding in the United States and many patients Pirofski and her colleagues at Bellevue cared for were suffering and dying from the disease.
[8] Pirofski was appointed chief of the division of infectious diseases at Albert Einstein College of Medicine and Montefiore Medical Center in 2006.
[10] She, along with colleagues in New York City and Connecticut, is leading a clinical trial of convalescent plasma, a form of antibody-based therapy for the disease.
[10] The treatment involves the administration of convalescent plasma, the liquid portion of blood containing antibodies to SARS-CoV-2, which is obtained from people who have recently recovered from COVID-19.
Pirofski has found the way in which recovered patients came forth to donate their plasma to treat others heartwarming and a celebration of their spirit and courage in wanting to help others and contribute to the advancement of evidence based science.
[16] Pirofski has been chief of the Division of Infectious Diseases and the Jacques and Selma Mitrani Chair in Biomedical Research at Albert Einstein College of Medicine and Montefiore Medical Center since 2006.